**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 67-68-5 |Methylsulfoxide | | 200-664-3 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: XI
Risk Phrases: 36/37/38
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Irritating to eyes, respiratory system and skin.Hygroscopic (absorbs
moisture from the air).
Potential Health Effects
Eye:
Produces irritation, characterized by a burning sensation, redness,
tearing, inflammation, and possible corneal injury. May cause
chemical conjunctivitis.
Skin:
May cause irritation with burning pain, itching and redness.
Substance is rapidly absorbed through the skin.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and
diarrhea. May cause liver and kidney damage. May cause garlic smell
on the breath and body.
Inhalation:
May cause respiratory tract irritation. Can produce delayed
pulmonary edema.
Chronic:
Prolonged or repeated skin contact may cause dermatitis. May cause
liver and kidney damage. Effects may be delayed.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Immediately flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15
minutes while removing contaminated clothing and shoes. Wash clothing
before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical
aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and
drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not
breathing, give artificial respiration. If breathing is difficult,
give oxygen. Get medical aid. Do NOT use mouth-to-mouth
resuscitation.
Notes to Physician:
Treat symptomatically and supportively.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. Vapors may form an explosive mixture with air.
During a fire, irritating and highly toxic gases may be generated by
thermal decomposition or combustion. Use water spray to keep
fire-exposed containers cool. Vapors may be heavier than air. They
can spread along the ground and collect in low or confined areas.
Containers may explode when heated.
Extinguishing Media:
Cool containers with flooding quantities of water until well after
fire is out. Use water spray, dry chemical, carbon dioxide, or
appropriate foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth),
then place in suitable container. Do not flush into a sewer. Clean
up spills immediately, observing precautions in the Protective
Equipment section. Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Avoid contact with eyes, skin, and clothing. Keep container tightly
closed. Avoid ingestion and inhalation. Use with adequate
ventilation. Wash clothing before reuse.
Storage:
Keep away from heat, sparks, and flame. Store in a tightly closed
container. Keep from contact with oxidizing materials. Store in a
cool, dry, well-ventilated area away from incompatible substances.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate
ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 67-68-5:
Germany: 160 mg/m3 TWA
Germany: Skin absorber
Netherlands: 50 ppm MAC; 150 mg/m3 MAC
Russia: 20 mg/m3 TWA
Personal Protective Equipment
Eyes:
Wear chemical splash goggles.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
A respiratory protection program that meets OSHA's 29
CFR 1910.134 and ANSI Z88.2 requirements or European
Standard EN 149 must be followed whenever workplace
conditions warrant respirator use.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Liquid
Color: Clear
Odor: slight odor - sulfurous odor - garlic-like odor
pH: Not available.
Vapor Pressure: 0.4 mm Hg at 20
Viscosity: 1.1cp @ 27 deg C
Boiling Point: 189 deg C
Freezing/Melting Point: 18.4 deg C
Autoignition Temperature: 215 deg C ( 419.00 deg F)
Flash Point: 95 deg C ( 203.00 deg F)
Explosion Limits, lower: 2.6 vol %
Explosion Limits, upper: 42 vol %
Decomposition Temperature: > 200 deg C
Solubility in water: Soluble.
Specific Gravity/Density: 1.1010g/cm3
Molecular Formula: C2H6OS
Molecular Weight: 78.13
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable at room temperature in closed containers under normal storage
and handling conditions.
Conditions to Avoid:
Excess heat.
Incompatibilities with Other Materials:
Strong oxidizing agents, strong acids, strong bases.
Hazardous Decomposition Products:
Carbon monoxide, oxides of sulfur, carbon dioxide.
Hazardous Polymerization: Has not been reported.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 67-68-5: PV6210000
LD50/LC50:
CAS# 67-68-5: Draize test, rabbit, eye: 100 mg; Draize test, rabbit,
eye: 500 mg/24H Mild; Draize test, rabbit, skin: 500 mg/24H Mild;
Oral, mouse: LD50 = 7920 mg/kg; Oral, rat: LD50 = 14500 mg/kg; Skin,
rat: LD50 = 40 gm/kg.
Carcinogenicity:
Methylsulfoxide -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
Other
For more information, see "HANDBOOK OF ENVIRONMENTAL FATE AND
EXPOSURE DATA."
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XI
Risk Phrases:
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 37/39 Wear suitable gloves and eye/face
protection.
WGK (Water Danger/Protection)
CAS# 67-68-5: 1
Canada
CAS# 67-68-5 is listed on Canada's DSL List.
CAS# 67-68-5 is listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 67-68-5 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 1/16/2002 Revision #2 Date: 10/05/2004
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
2-(3,4-Dimethoxyphenyl)-Ethylamine, 98%
| 120-20-7 |
|
2-Bromo-9-Fluorenone, 95%
| 3096-56-8 |
|
Potassium trihydrogen dioxalate dihydrate, 99%
| 6100-20-5 |
|
2-Chloromethyl-5-(4-Methoxyphenyl)-1,2,4-Oxadiazole, 98%
| 24023-71-0 |
|
2-Chloromethyl-5-(4-Chlorophenyl)-1,2,4-Oxadiazole, 98%
| 24068-15-3 |
|
Tetramethylgermanium, 97%
| 865-52-1 |
|
Phenyltosylate
| 640-60-8 |
|
Tetra-n-butylammonium hexafluorophosphate, 98%
| 3109-63-5 |
|
4-Methyl-2-nitrophenol, 99%
| 119-33-5 |
|
Tetraphenylgermanium, 97%
| 1048-05-1 |
|
2,3-Dibromopropionic Acid, 99%
| 600-05-5 |
|
Magnesium trifluoromethanesulfonate, 98%
| 60871-83-2 |
|
Tetraethyl orthocarbonate, 97%
| 78-09-1 |
|
N-(8-Bromooctyl)phthalimide
| 17702-83-9 |
|
4-Chloro-2-nitrophenol, 98%
| 89-64-5 |
|
cis-N-(4-Chlorobutenyl)Phthalimide, 97%
| 84347-67-1 |
|
4-Fluoro-o-xylene, 98%
| 452-64-2 |
|
2-Phenylglutaric anhydride, 97%
| 2959-96-8 |
|
Methyl tiglate, 98%
| 6622-76-0 |
|
Lobeline sulfate, 99%
| 134-64-5 |
|
Methyl triphenylarsonium iodide, 98%
| 1499-33-8 |
|
Hexa-n-butylditin, 98%
| 813-19-4 |
|
Hydrocortisone, 98%
| 50-23-7 |
|
Benzylurea, 93%
| 538-32-9 |
|
Dichloromethane, peptide synthesis grade, stabilized
| 75-09-2 |
|
N,N-Dicyclohexylcarbodiimide, 0.1M solution in dichloromethane,
| 75-09-2 |
|
N,N'-Dicyclohexylcarbodiimide, 1M solution in N-methylpyrrolidone,
| 538-75-0 |
|
N,N-Dimethylformamide, peptide synthesis grade
| 68-12-2 |
|
1,1,1,3,3,3-Hexafluoro-2-propanol, peptide synthesis grade
| 920-66-1 |
|
alpha,alpha,alpha',alpha',-Tetrachloro-p-xylene
| 7398-82-5 |
|
Bromine Water
| 7726-95-6 |
|
1,1,1,3,3,3-Hexafluoro-2-propanol, 10% in dichloromethane, peptide
| 75-09-2 |
|
1-Methyl-2-pyrrolidone, special automatic peptide synthesizer grade
| 872-50-4 |
|
N-Methylpyrrolidone, peptide synthesis grade
| 872-50-4 |
|
Methylsulfoxide, peptide synthesis grade
| 67-68-5 |
|
Ferrocene, 98%
| 102-54-5 |
|
1,2-Diiodotetrafluoroethane, 98%
| 354-65-4 |
|
5-Chlorothiophene-2-carboxylic acid, 98%
| 24065-33-6 |
|
trans-4-Methoxycinnamaldehyde, 98%
| 24680-50-0 |
|
trans-2-Methyl-2-butenal
| 497-03-0 |
|
Ethyl 3-phenylpropionate, 98%
| 2021-28-5 |
|
Allyl chloroformate, 97%
| 2937-50-0 |
|
2-Amino-3,3-dimethylbutane, 98%
| 3850-30-4 |
|
4-Tert-Butylbenzonitrile, 98%
| 4210-32-6 |
|
3-Aminopropionitrile, stabilized, 98%
| 151-18-8 |
|
4-Chlorophenylsulfonylacetonitrile, 98%
| 1851-09-8 |
|
p-Toluenesulfonylacetonitrile, 98%
| 5697-44-9 |
|
Methyl thiophene-2-carboxylate, 98%
| 5380-42-7 |
|
n-Amylbenzoate, 98%
| 2049-96-9 |
|
Isosorbide, 98%
| 652-67-5 |
|
|